AGP Executive Report
Last update: 12 hours agoEbola watch tightens: Australia is considering tighter travel restrictions as the Ebola outbreak escalates in Central Africa, with the latest reports pointing to rising deaths and cases in the Democratic Republic of Congo and Uganda, plus an American case flown out for treatment. Public health pressure: The WHO has declared the outbreak a public health emergency of international concern, while international response efforts ramp up with treatment centres and protections for health workers. Local health support: Northeast Health Wangaratta is recognising more than 150 volunteers during National Volunteer Week, highlighting hands-on roles from patient support to comfort for children. Care and regulation moves: Headsafe says it has received an MDSAP certificate to support its regulatory pathway in Australia and other markets. Health tech and trials: Alterity Therapeutics presented Phase 2 progress for MSA drug ATH434, while Propanc Biopharma lined up GMP production for a PRP Phase 1b study.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
